46 Results for "

SARM

" in MedChemExpress (MCE) Product Catalog:
Products (46)

46 Results for "SARM" in MCE Product Catalog:

10
10 Publications Verification
Cat. No.: HY-W021879
CAS No.: 58142-99-7
Synonyms: 5-Iodoisoquinoline
Domaines de recherche:  

Neurological Disease

DSRM-3716 (5-Iodoisoquinoline) is a potent and selective SARM1 NADase inhibitor with an IC50 of 75 nM. DSRM-3716 is selective against other NAD +-processing enzymes, receptors, and transporters. DSRM-3716 provides robust axon protection .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-129522
CAS No.: 1374663-29-2
Pureté:  99.18%
Synonyms: CZ-48
Domaines de recherche:  

Neurological Disease

Sulfo-ara-F-NMN (CZ-48) is a mimetic of nicotinamide mononucleotide (NMN). Sulfo-ara-F-NMN acts selectively, activating SARM1 but inhibiting CD38 (IC50 around 10 μM). Sulfo-ara-F-NMN induces intracellular cyclic ADP-ribose (cADPR) production .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-114530
CAS No.: 1029692-15-6
Pureté:  99.93%
Target:  

Androgen Receptor

Domaines de recherche:  

Metabolic Disease Cancer

LY2452473 is an orally bioavailable, selective androgen receptor modulator (SARM).
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-14383
CAS No.: 1182367-47-0
Pureté:  99.80%
Synonyms: RAD140; EP0062
Target:  

Androgen Receptor

Domaines de recherche:  

Neurological Disease Endocrinology Cancer

Vosilasarm (RAD140) is a potent, orally active, nonsteroidal selective androgen receptor modulator (SARM) with a Ki of 7 nM. Vosilasarm shows good selectivity over other steroid hormone nuclear receptors .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-112256
CAS No.: 899821-23-9
Pureté:  98.99%
Target:  

Androgen Receptor

Domaines de recherche:  

Inflammation/Immunology

ACP-105 is an orally available, selective amd potent androgen receptor modulator (SARM), with pEC50s of 9.0 and 9.3 for AR wild type and T877A mutant, respectively.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-100186
CAS No.: 1539314-06-1
Pureté:  99.74%
GSK-2881078 is an orally active and nonsteroidal selective androgen receptor modulator (SARM) which act as partial AR agonists in androgenic tissues while mainly as complete AR agonists in synthetic metabolic tissues,induces AR-mediated transcriptional activation in PC3(AR)2 cells (EC50 = 3.99 nM) and the effect can be inhibited by the non-steroidal AR antagonist Bicalutamide. GSK-2881078 can be used in research of muscle weakness and cachexia associated with both chronic and acute illness .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-13273
CAS No.: 841205-47-8
Pureté:  99.90%
Synonyms: MK-2866; GTX-024; EnoboSARM
Target:  

Androgen Receptor

Domaines de recherche:  

Others Cancer

Ostarine (MK-2866) is a selective androgen receptor modulator (SARMs) that regulates cardiomyocyte function, improves bone healing, regulates uterine function, and influences muscle tissue metabolism .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-11027
CAS No.: 606101-58-0
Pureté:  99.92%
Synonyms: PF-05314882
Target:  

Androgen Receptor

Domaines de recherche:  

Endocrinology

MK-0773 is a selective androgen receptor modulators (SARMs) that binds to AR with an IC50 of 6.6 nM.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-12023
CAS No.: 401900-40-1
Pureté:  99.61%
Synonyms: S-4
Target:  

Androgen Receptor

Domaines de recherche:  

Cancer

GTx-007 (S-4) is an orally active and selective nonsteroidal androgen receptor (AR) modulator (SARM) and a partial agonist, with Ki of 4 nM. GTx-007 (S-4) is identified as SARMs with potent and tissue-selective in vivo pharmacological activity .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-103576
CAS No.: 917891-35-1
Pureté:  99.57%
Target:  

Androgen Receptor

Domaines de recherche:  

Endocrinology

LGD-3303 is a selective androgen receptor modulator (SARM).
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-Z0816
CAS No.: 87375-91-5
Target:  

Calcium Channel

Domaines de recherche:  

Others

Dehydronitrosonisoldipine, a derivative of Nisoldipine (HY-17402), is an irreversible and cell-permeant sterile alpha and TIR motif-containing 1 (SARM1) inhibitor. Dehydronitrosonisoldipine acts mainly by blocking SARM1 activation but not its enzymatic activities. Dehydronitrosonisoldipine inhibits SARM1 and axon degenration (AxD) by covalently modifying cysteines, also inhibits the Vincristine-activated cADPR production in neurons. Dehydronitrosonisoldipine can be used for researching neurodegenerative disorders .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0985
CAS No.: 136-40-3
Target:  

TRP Channel

Domaines de recherche:  

Neurological Disease

Phenazopyridine hydrochlorideis a competitive SARM1 inhibitor, with IC50 145 μM. Phenazopyridine hydrochlorideis a TRPM8 antagonist. Phenazopyridine hydrochloride has a local anesthetic/analgesic effect. Phenazopyridine hydrochlorideis used to relieve painful symptoms of conditions such as cystitis and urethritis. Phenazopyridine hydrochloridecan promote neuronal differentiation and can also be used in the study of traumatic brain injury, peripheral neuropathy and neurodegenerative diseases .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0985A
CAS No.: 94-78-0
Target:  

TRP Channel

Domaines de recherche:  

Neurological Disease

Phenazopyridine is a competitive SARM1 inhibitor, with IC50 145 μM. Phenazopyridine is a TRPM8 antagonist. Phenazopyridine has a local anesthetic/analgesic effect. Phenazopyridine is used to relieve painful symptoms of conditions such as cystitis and urethritis. Phenazopyridine can promote neuronal differentiation and can also be used in the study of traumatic brain injury, peripheral neuropathy and neurodegenerative diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-128700
CAS No.: 321-02-8
Nicotinic acid mononucleotide acts as a SARM1 inhibitor and a NAD + biosynthesis intermediate, with an IC50 value of 93.3 μM against SARM1. Nicotinic acid mononucleotide exerts axon-protective effects, delays axonal degeneration, elevates NAD + levels, enhances Sirt1 activity, improves myocardial capillary density and alleviates myocardial fibrosis. Nicotinic acid mononucleotide reverses diabetic cardiomyopathy in diabetic mice by increasing myocardial NAD + levels. Nicotinic acid mononucleotide is applicable to research related to cancer, multiple sclerosis, diabetic cardiomyopathy, neurodegenerative diseases and Huntington's disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-122025
CAS No.: 870888-46-3
Pureté:  99.94%
Target:  

Androgen Receptor

Domaines de recherche:  

Metabolic Disease

AC-262536 is a selective and non-steroidal androgen receptor modulators (SARMs) with beneficial anabolic effects. AC-262536 exhibits potent agonist activity at the androgen receptor, with an affinity in the low nanomolar range (1-10 nM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-112257
CAS No.: 1010396-29-8
Pureté:  99.93%
Target:  

Androgen Receptor

Domaines de recherche:  

Metabolic Disease

S-23 is an orally active selective androgen receptor modulator (SARM) with a Ki of 1.7 nM. S-23 induces androgen receptor (AR)-mediated transcriptional activation in CV-1 cells. S-23 increases prostate, seminal vesicle, and levator ani muscle weights in castrated rats .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-128700A
Pureté:  98.28%
Domaines de recherche:  

Metabolic Disease

Nicotinic acid mononucleotide triethylamine acts as a SARM1 inhibitor and a NAD + biosynthesis intermediate, with an IC50 value of 93.3 μM against SARM1. Nicotinic acid mononucleotide triethylamine exerts axon-protective effects, delays axonal degeneration, elevates NAD + levels, enhances Sirt1 activity, improves myocardial capillary density and alleviates myocardial fibrosis. Nicotinic acid mononucleotide triethylamine reverses diabetic cardiomyopathy in diabetic mice by increasing myocardial NAD + levels. Nicotinic acid mononucleotide triethylamine is applicable to research related to cancer, multiple sclerosis, diabetic cardiomyopathy, neurodegenerative diseases and Huntington's disease .
loading...
    loading...
Cat. No.: HY-178159
CAS No.: 2244341-81-7
Target:  

RNA MTase

Domaines de recherche:  

Inflammation/Immunology

SA91-0178 is a METTL1 inhibitor. SA91-0178 inhibits m 7G methylation of RNA, reduces SARM1 stability, mitigates NAD + depletion and metabolic reprogramming in macrophages. SA91-0178 demonstrates excellent protective efficacy against multiple organ injury in cecal ligation and puncture (CLP)-induced and ischemia/reperfusion (I/R)-induced mice. SA91-0178 can be used for the study of systemic inflammatory diseases .
loading...
    loading...
Cat. No.: HY-145917
CAS No.: 2396592-52-0
Pureté:  99.34%
Domaines de recherche:  

Neurological Disease

SARM1-IN-2 (Example 82) is a SARM1 inhibitor (IC50 <1 μM) that inhibits axon regeneration. Axon regeneration refers to the process by which neuronal axons attempt to restore their structure and function after axonal degeneration. SARM1-IN-2 inhibits axon regeneration by reducing or inhibiting the binding of SARM1 to NAD+. SARM1-IN-2 can be used to study axonal degeneration .
loading...
    loading...
Cat. No.: HY-176487
CAS No.: 3080315-51-8
Domaines de recherche:  

Neurological Disease

SARM1-IN-6 (Compound 22b) is a brain-permeable SARM1 orthosteric inhibitor, the IC50 of SARM1-IN-6 against NAM is 0.069 μM .
loading...
    loading...